{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T17:14:35Z","timestamp":1792602875058,"version":"4.5.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T00:00:00Z","timestamp":1768176000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T00:00:00Z","timestamp":1768262400000},"content-version":"vor","delay-in-days":1,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-31085-z","type":"journal-article","created":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T13:05:15Z","timestamp":1768223115000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Potent LeuBAT inhibitors designed in silico as next-generation duloxetine analogs for enhanced major depressive disorder treatment"],"prefix":"10.1038","volume":"16","author":[{"given":"Mehdi","family":"Yoosefian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hedieh","family":"Bayramzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kasim Sakran","family":"Abass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tahmineh","family":"Mokhtari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,12]]},"reference":[{"key":"31085_CR1","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.jad.2022.12.055","volume":"324","author":"N Karami","year":"2023","unstructured":"Karami, N. et al. Global prevalence of depression, anxiety, and stress in cardiac patients: A systematic review and meta-analysis. J. Affect. Disord. 324, 175\u2013189 (2023).","journal-title":"J. Affect. Disord."},{"issue":"4","key":"31085_CR2","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1093\/schbul\/sbae063","volume":"50","author":"J Liang","year":"2024","unstructured":"Liang, J. et al. Unraveling the prefrontal cortex-basolateral amygdala pathway\u2019s role on schizophrenia\u2019s cognitive impairments: a multimodal study in patients and mouse models. Schizophr. Bull. 50 (4), 913\u2013923 (2024).","journal-title":"Schizophr. Bull."},{"issue":"2","key":"31085_CR3","first-page":"173","volume":"107","author":"H Kovich","year":"2023","unstructured":"Kovich, H., Kim, W. & Quaste, A. M. Pharmacologic treatment of depression. Am. Family Phys. 107 (2), 173\u2013181 (2023).","journal-title":"Am. Family Phys."},{"key":"31085_CR4","doi-asserted-by":"publisher","first-page":"0537","DOI":"10.34133\/research.0537","volume":"7","author":"F Luo","year":"2024","unstructured":"Luo, F. et al. Deciphering and targeting the ESR2\u2013miR-10a-5p\u2013BDNF axis in the prefrontal cortex: advancing postpartum depression Understanding and therapeutics. Research 7, 0537 (2024).","journal-title":"Research"},{"key":"31085_CR5","doi-asserted-by":"publisher","first-page":"554899","DOI":"10.3389\/fpsyt.2020.554899","volume":"11","author":"D Rodrigues-Amorim","year":"2020","unstructured":"Rodrigues-Amorim, D. et al. A systematic review of efficacy, safety, and tolerability of Duloxetine. Front. Psychiatry. 11, 554899 (2020).","journal-title":"Front. Psychiatry"},{"key":"31085_CR6","doi-asserted-by":"publisher","first-page":"109436","DOI":"10.1016\/j.intimp.2022.109436","volume":"113","author":"L Wang","year":"2022","unstructured":"Wang, L. et al. Pexidartinib (PLX3397) through restoring hippocampal synaptic plasticity ameliorates social isolation-induced mood disorders. Int. Immunopharmacol. 113, 109436 (2022).","journal-title":"Int. Immunopharmacol."},{"issue":"2","key":"31085_CR7","doi-asserted-by":"publisher","first-page":"e082853","DOI":"10.1136\/bmjopen-2023-082853","volume":"15","author":"F Siddiqui","year":"2025","unstructured":"Siddiqui, F. et al. Beneficial and harmful effects of Duloxetine versus placebo,\u2018active placebo\u2019or no intervention for adults with major depressive disorder: a systematic review with meta-analysis and trial sequential analysis of randomised clinical trials. BMJ open. 15 (2), e082853 (2025).","journal-title":"BMJ open."},{"issue":"2","key":"31085_CR8","doi-asserted-by":"publisher","first-page":"24","DOI":"10.64719\/pb.4519","volume":"55","author":"A Malik","year":"2025","unstructured":"Malik, A. et al. Serotonin and norepinephrine reuptake inhibitors (SNRIs) for treatment of fibromyalgia: A comprehensive clinical review. Psychopharmacol. Bull. 55 (2), 24\u201340 (2025).","journal-title":"Psychopharmacol. Bull."},{"key":"31085_CR9","first-page":"122","volume":"47","author":"M Filocco","year":"2023","unstructured":"Filocco, M. The hidden withdrawal epidemic of cymbalta (Duloxetine): the inequities of the learned intermediary doctrine in cymbalta litigation and the necessity of an FDA Re-Evaluation. Seton Hall Legis J. 47, 122 (2023).","journal-title":"Seton Hall Legis J."},{"key":"31085_CR10","doi-asserted-by":"publisher","first-page":"176759","DOI":"10.1016\/j.ejphar.2024.176759","volume":"978","author":"GJ Zou","year":"2024","unstructured":"Zou, G. J. et al. Microglial activation in the medial prefrontal cortex after remote fear recall participates in the regulation of auditory fear extinction. Eur. J. Pharmacol. 978, 176759 (2024).","journal-title":"Eur. J. Pharmacol."},{"issue":"3","key":"31085_CR11","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.ejpsy.2020.10.001","volume":"35","author":"M Hansbauer","year":"2021","unstructured":"Hansbauer, M. & Strauss, C. Severe serotonin syndrome under Duloxetine in a patient with coeliac disease\u2014is there a connection? A case report. Eur. J. Psychiatry. 35 (3), 193\u2013196 (2021).","journal-title":"Eur. J. Psychiatry"},{"issue":"1","key":"31085_CR12","doi-asserted-by":"publisher","first-page":"47","DOI":"10.3928\/00485713-20230105-02","volume":"53","author":"V Soal","year":"2023","unstructured":"Soal, V., Tiongko, J. L. & Sedky, K. Duloxetine and hepatic injury: A case presentation. Psychiatric Annals. 53 (1), 47\u201351 (2023).","journal-title":"Psychiatric Annals"},{"issue":"10S","key":"31085_CR13","doi-asserted-by":"publisher","first-page":"S2765","DOI":"10.14309\/01.ajg.0001046572.84038.03","volume":"119","author":"A Mohammadi","year":"2024","unstructured":"Mohammadi, A. S4301 Duloxetine dilemma: unmasking the hidden threat of liver injury. Official J. Am. Coll. Gastroenterology| ACG. 119 (10S), S2765\u2013S2766 (2024).","journal-title":"Official J. Am. Coll. Gastroenterology| ACG"},{"key":"31085_CR14","doi-asserted-by":"publisher","first-page":"114333","DOI":"10.1016\/j.ab.2021.114333","volume":"630","author":"JY Lu","year":"2021","unstructured":"Lu, J. Y. et al. Peptide-based system for sensing Pb2\u2009+\u2009and molecular logic computing. Anal. Biochem. 630, 114333 (2021).","journal-title":"Anal. Biochem."},{"issue":"9","key":"31085_CR15","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1111\/j.1365-2036.2010.04449.x","volume":"32","author":"R Vuppalanchi","year":"2010","unstructured":"Vuppalanchi, R. et al. Duloxetine hepatotoxicity: a case-series from the drug\u2010induced liver injury network. Aliment. Pharmacol. Ther. 32 (9), 1174\u20131183 (2010).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"31085_CR16","doi-asserted-by":"crossref","unstructured":"Hole, K. et al. Effect of CYP2D6 Genotype on Duloxetine Serum Concentration Vol. 134, p. 186\u2013192 (Basic & Clinical Pharmacology & Toxicology, 2024). 1.","DOI":"10.1111\/bcpt.13954"},{"key":"31085_CR17","doi-asserted-by":"publisher","first-page":"603615","DOI":"10.3389\/fimmu.2020.603615","volume":"11","author":"X Tang","year":"2021","unstructured":"Tang, X. et al. Indicator regularized non-negative matrix factorization method-based drug repurposing for COVID-19. Front. Immunol. 11, 603615 (2021).","journal-title":"Front. Immunol."},{"issue":"21","key":"31085_CR18","doi-asserted-by":"publisher","first-page":"10432","DOI":"10.3390\/ijms262110432","volume":"26","author":"SAH Abdi","year":"2025","unstructured":"Abdi, S. A. H. et al. Duloxetine, an SNRI, targets pSTAT3 signaling: In-Silico, RNA-Seq and In-Vitro evidence for a pleiotropic mechanism of pain relief. Int. J. Mol. Sci. 26 (21), 10432 (2025).","journal-title":"Int. J. Mol. Sci."},{"issue":"12","key":"31085_CR19","doi-asserted-by":"publisher","first-page":"3083","DOI":"10.1007\/s13346-022-01172-z","volume":"12","author":"HF Salem","year":"2022","unstructured":"Salem, H. F. et al. Glycerosomal thermosensitive in situ gel of Duloxetine HCl as a novel nanoplatform for rectal delivery: in vitro optimization and in vivo appraisal. Drug Delivery Translational Res. 12 (12), 3083\u20133103 (2022).","journal-title":"Drug Delivery Translational Res."},{"key":"31085_CR20","unstructured":"Sadashivaiah, R. Development and Evaluation of Transdermal Drug Delivery Systems for Anti Parkinsons and Antipsychotic Drugs (Rajiv Gandhi University of Health Sciences (India), 2021)."},{"issue":"1","key":"31085_CR21","doi-asserted-by":"publisher","first-page":"10","DOI":"10.33435\/tcandtc.1196019","volume":"8","author":"E Edache","year":"2024","unstructured":"Edache, E. et al. Molecular phylogeny, Sequence-based drug design, Docking built virtual screening, dynamics simulations, and ADMET properties of Thiazolino 2-pyridone amide derivatives as an inhibitor of chlamydia trachomatis and SARS-CoV-2 protein. Turkish Comput. Theoretical Chem. 8 (1), 10\u201339 (2024).","journal-title":"Turkish Comput. Theoretical Chem."},{"issue":"1","key":"31085_CR22","doi-asserted-by":"publisher","first-page":"102","DOI":"10.3390\/biom10010102","volume":"10","author":"I G\u00f3ral","year":"2020","unstructured":"G\u00f3ral, I., \u0141\u0105tka, K. & Bajda, M. Structure modeling of the norepinephrine transporter. Biomolecules 10 (1), 102 (2020).","journal-title":"Biomolecules"},{"key":"31085_CR23","first-page":"157","volume":"77","author":"A Esmaeili","year":"2023","unstructured":"Esmaeili, A., Yoosefian, M. & Mahani, M. Molecular dynamics simulation of Lenalidomide interaction with cRBN protein: a target for Immunomodulatory drugs. S. Afr. J. Chem. 77, 157\u2013162 (2023).","journal-title":"S. Afr. J. Chem."},{"key":"31085_CR24","doi-asserted-by":"publisher","first-page":"105523","DOI":"10.1016\/j.compbiomed.2022.105523","volume":"145","author":"M Yoosefian","year":"2022","unstructured":"Yoosefian, M., Moghani, M. Z. & Juan, A. Silico evaluation of Atazanavir as a potential HIV main protease inhibitor and its comparison with new designed analogs. Comput. Biol. Med. 145, 105523 (2022).","journal-title":"Comput. Biol. Med."},{"key":"31085_CR25","doi-asserted-by":"crossref","unstructured":"Yoosefian, M. Designing new pharmaceutical derivatives for potential Inhibition of human immunodeficiency virus protease enzyme Inhibition; a comprehensive in Silico study. J. Biomol. Struct. Dynamics, : pp. 1\u201322. (2025).","DOI":"10.1080\/07391102.2025.2490791"},{"issue":"1","key":"31085_CR26","doi-asserted-by":"publisher","first-page":"27367","DOI":"10.1038\/s41598-025-08370-y","volume":"15","author":"D Gheidari","year":"2025","unstructured":"Gheidari, D. et al. Computational studies on structural aspects of Pyrazolo [3, 4-b] pyridine derivatives as TRKA inhibitors in cancer therapy. Sci. Rep. 15 (1), 27367 (2025).","journal-title":"Sci. Rep."},{"issue":"24","key":"31085_CR27","doi-asserted-by":"publisher","first-page":"13830","DOI":"10.1080\/07391102.2023.2279269","volume":"42","author":"FA Ugbe","year":"2024","unstructured":"Ugbe, F. A. et al. Cheminformatics-based discovery of new organoselenium compounds with potential for the treatment of cutaneous and visceral leishmaniasis. J. Biomol. Struct. Dynamics. 42 (24), 13830\u201313853 (2024).","journal-title":"J. Biomol. Struct. Dynamics"},{"issue":"1","key":"31085_CR28","doi-asserted-by":"publisher","first-page":"9","DOI":"10.33435\/tcandtc.1003157","volume":"6","author":"E Edache","year":"2022","unstructured":"Edache, E. et al. Investigation of Salicylidene acylhydrazides derivatives: molecular Docking, ADMET, and molecular dynamic simulations were used in conjunction towards the design of new yersinia pseudotuberculosis inhibitors. Turkish Comput. Theoretical Chem. 6 (1), 9\u201330 (2022).","journal-title":"Turkish Comput. Theoretical Chem."},{"issue":"1","key":"31085_CR29","doi-asserted-by":"publisher","first-page":"37723","DOI":"10.1038\/s41598-025-24847-2","volume":"15","author":"NS Orujova","year":"2025","unstructured":"Orujova, N. S. et al. In vitro, in silico, and DFT evaluation of antimicrobial imidazole derivatives with insights into mechanism of action. Sci. Rep. 15 (1), 37723 (2025).","journal-title":"Sci. Rep."},{"issue":"18","key":"31085_CR30","doi-asserted-by":"publisher","first-page":"5760","DOI":"10.1039\/D5NA00182J","volume":"7","author":"Z Sadeghian","year":"2025","unstructured":"Sadeghian, Z., Bayat, M. & Gheidari, D. Synthesis, molecular docking, Pharmacological evaluation, MD simulation, and DFT calculations of quinazolin-12-one derivatives as PDK1 inhibitors. Nanoscale Adv. 7 (18), 5760\u20135783 (2025).","journal-title":"Nanoscale Adv."},{"issue":"10","key":"31085_CR31","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1080\/03067319.2019.1685664","volume":"101","author":"S Ahmadzadeh","year":"2021","unstructured":"Ahmadzadeh, S., Yoosefian, M. & Rezayi, M. Comprehensive experimental and theoretical investigations on chromium (III) trace detection in biological and environmental samples using polymeric membrane sensor. Int. J. Environ. Anal. Chem. 101 (10), 1461\u20131476 (2021).","journal-title":"Int. J. Environ. Anal. Chem."},{"issue":"1","key":"31085_CR32","doi-asserted-by":"publisher","first-page":"38668","DOI":"10.1038\/s41598-025-96866-y","volume":"15","author":"MG Abd-Almutalib","year":"2025","unstructured":"Abd-Almutalib, M. G. & Naser, N. Computational and molecular Docking analysis of a novel Azo compound and its nanocomposite biopolymer synthesized via a single-pot method. Sci. Rep. 15 (1), 38668 (2025).","journal-title":"Sci. Rep."},{"key":"31085_CR33","doi-asserted-by":"crossref","unstructured":"Masoumi, Z., Bayat, M. & Gheidari, D. In Silico Study of Bis (6-Amino\u20101, 3\u2010Dimethylpyrimidine\u20102, 4 (1H, 3H)\u2010Diones) as EGFR Inhibitors: Synthesis, DFT, Molecular Docking, and MD Simulation Studies. Cellular Microbiology, 2025(1): p. 5585552. (2025).","DOI":"10.1155\/cmi\/5585552"},{"key":"31085_CR34","doi-asserted-by":"publisher","first-page":"127304","DOI":"10.1016\/j.molliq.2025.127304","volume":"426","author":"M Yoosefian","year":"2025","unstructured":"Yoosefian, M. et al. Evaluation of the effect of Sofosbuvir as an inhibitor of hepatitis C virus and an in-depth comparative analysis with advanced analogues. J. Mol. Liq. 426, 127304 (2025).","journal-title":"J. Mol. Liq."},{"issue":"1","key":"31085_CR35","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s43141-022-00362-z","volume":"20","author":"EI Edache","year":"2022","unstructured":"Edache, E. I. et al. QSAR, homology modeling, and Docking simulation on SARS-CoV-2 and Pseudomonas aeruginosa inhibitors, ADMET, and molecular dynamic simulations to find a possible oral lead candidate. J. Genetic Eng. Biotechnol. 20 (1), 88 (2022).","journal-title":"J. Genetic Eng. Biotechnol."},{"key":"31085_CR36","doi-asserted-by":"crossref","unstructured":"Ganiev, B., Mardonov, U. & Kholikova, G. Molecular structure, HOMO-LUMO, MEP-\u2013Analysis of triazine compounds using DFT (B3LYP) calculations. Materials Today: Proceedings, (2023).","DOI":"10.1016\/j.matpr.2023.09.191"},{"issue":"1","key":"31085_CR37","doi-asserted-by":"publisher","first-page":"22801","DOI":"10.1038\/s41598-024-72846-6","volume":"14","author":"NM Sabry","year":"2024","unstructured":"Sabry, N. M. et al. Electronic structure, global reactivity descriptors and nonlinear optical properties of Glycine interacted with ZnO, MgO and CaO for bacterial detection. Sci. Rep. 14 (1), 22801 (2024).","journal-title":"Sci. Rep."},{"issue":"5","key":"31085_CR38","doi-asserted-by":"publisher","first-page":"2650","DOI":"10.1039\/C9RA09243A","volume":"10","author":"M Yoosefian","year":"2020","unstructured":"Yoosefian, M. et al. Ultra-low concentration protein detection based on phenylalanine\u2013Pd\/SWCNT as a high sensitivity nanoreceptor. RSC Adv. 10 (5), 2650\u20132660 (2020).","journal-title":"RSC Adv."},{"key":"31085_CR39","doi-asserted-by":"crossref","unstructured":"Edache, E. I. et al. Pharmacophore modeling, 2D-QSAR, Drug likeness and toxicity prediction of 2-aziridinyl-and 2, 3-bis (aziridinyl)-1, 4-naphthoquinonyl sulfonate and acylate derivatives as multifunctional agents for the treatment of malaria parasite, Plasmodium falciparum. NAM Journal, : p. 100019. (2025).","DOI":"10.1016\/j.namjnl.2025.100019"},{"issue":"10","key":"31085_CR40","first-page":"7260","volume":"14","author":"H Luo","year":"2022","unstructured":"Luo, H. et al. Research progress of Apelin in acute ischemic brain injury. Am. J. Translational Res. 14 (10), 7260 (2022).","journal-title":"Am. J. Translational Res."},{"issue":"W1","key":"31085_CR41","doi-asserted-by":"publisher","first-page":"W257","DOI":"10.1093\/nar\/gky318","volume":"46","author":"P Banerjee","year":"2018","unstructured":"Banerjee, P. et al. ProTox-II: a webserver for the prediction of toxicity of chemicals. Nucleic Acids Res. 46 (W1), W257\u2013W263 (2018).","journal-title":"Nucleic Acids Res."},{"issue":"3","key":"31085_CR42","first-page":"346","volume":"2","author":"EI Edache","year":"2024","unstructured":"Edache, E. I. et al. Evaluation of novel Anti-SARS-CoV-2 compounds by targeting nucleoprotein and envelope protein through homology modeling, Docking simulations, ADMET, and molecular dynamic simulations with the MM\/GBSA calculation. Intell. Pharm. 2 (3), 346\u2013366 (2024).","journal-title":"Intell. Pharm."},{"issue":"1","key":"31085_CR43","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s44371-025-00184-1","volume":"2","author":"EI Edache","year":"2025","unstructured":"Edache, E. I. et al. Mechanism of action of substituted peramivir phosphonate derivatives as potent oseltamivir-resistant influenza A virus using molecular docking, molecular dynamics simulations, and free energies calculations. Discover Chem. 2 (1), 99 (2025).","journal-title":"Discover Chem."},{"key":"31085_CR44","doi-asserted-by":"crossref","unstructured":"Woldekidan, H. B. & Woldesemayat, A. A. In Silico Method for ssDNA Aptamer Binding with Aurora Kinase A Protein (Springer, 2025).","DOI":"10.1007\/7651_2024_596"},{"key":"31085_CR45","doi-asserted-by":"publisher","first-page":"114736","DOI":"10.1016\/j.molliq.2020.114736","volume":"324","author":"M Mahani","year":"2021","unstructured":"Mahani, M. et al. LSPR biosensing for the early-stage prostate cancer detection using hydrogen bonds between PSA and antibody: molecular dynamic and experimental study. J. Mol. Liq. 324, 114736 (2021).","journal-title":"J. Mol. Liq."},{"issue":"9","key":"31085_CR46","doi-asserted-by":"publisher","first-page":"105051","DOI":"10.1016\/j.arabjc.2023.105051","volume":"16","author":"M Yoosefian","year":"2023","unstructured":"Yoosefian, M. et al. A suitable drug structure for interaction with SARS-CoV\u20102 main protease between boceprevir, masitinib and rupintrivir; a molecular dynamics study. Arab. J. Chem. 16 (9), 105051 (2023).","journal-title":"Arab. J. Chem."},{"issue":"3","key":"31085_CR47","doi-asserted-by":"publisher","first-page":"229","DOI":"10.33084\/bjop.v6i3.4915","volume":"6","author":"EI Edache","year":"2023","unstructured":"Edache, E. I. et al. 2D-QSAR, docking, molecular dynamics simulations with the MM\/GBSA approaches against graves\u2019 disease and PTPN22. Borneo J. Pharm. 6 (3), 229\u2013248 (2023).","journal-title":"Borneo J. Pharm."},{"key":"31085_CR48","doi-asserted-by":"publisher","first-page":"146572","DOI":"10.1016\/j.apsusc.2020.146572","volume":"524","author":"M Yoosefian","year":"2020","unstructured":"Yoosefian, M. et al. Molecular dynamics simulations on interaction of ssDNA-causing DM1 with carbon and Boron nitride nanotubes to inhibit the formation of CTG repeat secondary structures. Appl. Surf. Sci. 524, 146572 (2020).","journal-title":"Appl. Surf. Sci."},{"key":"31085_CR49","doi-asserted-by":"publisher","first-page":"1525533","DOI":"10.3389\/fddsv.2025.1525533","volume":"5","author":"D Gheidari","year":"2025","unstructured":"Gheidari, D., Mehrdad, M. & Etedali, M. Identification of natural compounds as potential inhibitors of Interleukin-23: virtual screening, ADMET, drug-likeness, and dynamic simulation. Front. Drug Discovery. 5, 1525533 (2025).","journal-title":"Front. Drug Discovery"},{"issue":"1","key":"31085_CR50","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s13065-025-01459-5","volume":"19","author":"Z Amiri","year":"2025","unstructured":"Amiri, Z., Bayat, M. & Gheidari, D. Synthesis of thiazoloquinolinone derivatives: molecular docking, MD simulation, and Pharmacological evaluation as VEGFR-2 inhibitors. BMC Chem. 19 (1), 90 (2025).","journal-title":"BMC Chem."},{"issue":"1","key":"31085_CR51","doi-asserted-by":"publisher","first-page":"36837","DOI":"10.1038\/s41598-025-20757-5","volume":"15","author":"N Masarkar","year":"2025","unstructured":"Masarkar, N. et al. Pharmacokinetic, docking, and DFT analyses reveal Moringa Oleifera phytochemicals as inhibitors of HIF-1\u03b1\/VEGF\/GLUT1 signaling pathway in breast cancer. Sci. Rep. 15 (1), 36837 (2025).","journal-title":"Sci. Rep."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-31085-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-31085-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-31085-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T23:02:54Z","timestamp":1768345374000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-31085-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,12]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["31085"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-31085-z","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,12]]},"assertion":[{"value":"26 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"As an in silico study, no human or animal subjects were involved. All computational work complied with ethical standards, using publicly available data (e.g., PDB: 4MM6) and licensed software.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Ethical approval"}}],"article-number":"1622"}}